Efficacy and safety of anti-amyloid-β monoclonal antibodies in current Alzheimer's disease phase III clinical trials: A systematic review and interactive web app-based meta-analysis
Danko Jeremic, Juan D. Navarro‐López, Lydia Jiménez‐Díaz
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/j.arr.2023.102012
- Published
- Jul 7, 2023
- Venue
- Ageing Research Reviews
- DOI
- 10.1016/j.arr.2023.102012
- PubMed
- 37423541
- Categories
- Alzheimer's disease research and treatments
- License
- other-oa
- Provenance
- openalex